MedTrace Logo

The Effect of Black Mulberry (Morus Nigra) Consumption on Cognitive Functions

NCT05406648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-06-06

No results posted yet for this study

Summary

The study was conducted with 44 patients who were diagnosed with mild-to-moderate Alzheimer's Disease. Participants were divided into 2 groups intervention group and the control group. The intervention group was administered 20 grams of black mulberry concentrate per day for 12 weeks and the control group received no intervention thorough the study. Cognitive functions, antioxidant capacity, and inflammation markers were evaluated at the baseline and at the end of the 12 weeks.

Conditions

  • Alzheimer Disease, Early Onset

Interventions

OTHER

Morus nigra concentrate

The experimental group was given 20 grams of black mulberry (morus nigra) concentrate per day for 12 weeks.

Sponsors & Collaborators

  • Yuksek Ihtisas University

    collaborator OTHER

  • Gulhane Training and Research Hospital

    collaborator OTHER_GOV

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Zeynep Goktas, PhD · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-08
Primary Completion
2020-03-17
Completion
2021-01-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406648 on ClinicalTrials.gov